S9562 HCPCS code: Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem

S9562 is the HCPCS Level II code for home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies.

Code details

FieldValue
SectionS codes — Temporary national codes (non-Medicare)
Coverage codeI — Not payable by Medicare
Pricing indicator00 — Not separately priced by Medicare
BETOS categoryZ2
Added2003-01-01
Last action effective2023-04-01

What changed for S9562

Frequently asked questions

What is HCPCS code S9562?

S9562 is the HCPCS Level II code for home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. Short descriptor: "Ht inj palivizumab/ab diem".

Does Medicare cover S9562?

Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.

Related S95 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All S codes · HCPCS lookup